Pediatric rheumatology

Ultrasound-detected tenosynovitis in ankles with clinical arthritis and short-term outcome of patients with new-onset juvenile idiopathic arthritis

Clin Exp RheumatolPublished Prospective cohort study

Main finding · Clinically inactive diseaseResult — go to the resultHazard ratio 1.12 95% CI 0.51–2.45

Authors' conclusion

US-detected tenosynovitis is frequent in ankles with clinical arthritis at JIA onset but does not impair the chance of achieving clinically inactive disease in the early disease phase.

Study context

Population
Children with new-onset juvenile idiopathic arthritis (JIA) and clinically active disease of the ankle
Participants
45 children
Exposure
Ultrasound (US)-detected tenosynovitis vs isolated arthritis of the ankle
  • Tenosynovitisn = 28
  • Isolated arthritisn = 17reference
Outcome
Achievement of clinically inactive disease
Follow-up
6 months after starting treatment
Methodological detailsKaplan-Meier method, Cox model
  • Kaplan-Meier method
  • Cox model

Main finding

Clinically inactive disease · 6 months

Hazard ratio

1.12

95% CI 0.51–2.45

By group

Tenosynovitisvs Isolated arthritis
HR 1.12 (95% CI 0.51–2.45)

As reported in the abstract

Observational data: associations, not effects.

Further findings

Frequency of US-detected ankle tenosynovitis

OutcomeTenosynovitisIsolated arthritisHR (95% CI)
Clinically inactive disease, excluding patients given biologics (subanalysis)64.7%54.5%1.56 (0.58–4.24)

Frequency of US-detected ankle tenosynovitis

Medial and lateral tendon compartments most frequently inflamed

US reliability (kappa)

The rate of US reliability was high

Original publication

Ultrasound-detected tenosynovitis in ankles with clinical arthritis and short-term outcome of patients with new-onset juvenile idiopathic arthritis. Clin Exp Rheumatol. Published 20 November 2023. doi:10.55563/clinexprheumatol/r35akp

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.